StockUK listing UK0QQJLSEEarnings Deterioration

Evolva Holding SA(0QQJ) Stock Analysis

GBP --+0.00%
Reward31Low
Risk38Moderate
75%Data
Revenue down 45% YoY
GBP —+0.00 (+0.00%) Previous close · LSE
Market cap 740.34M
Reward Ratingⓘ31 Low reward assessment · 75% data coverage
Bottom 1% of stocksView factors
Risk Ratingⓘ38 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on 0QQJ to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Evolva Holding SA?

EvoNext Holdings SA is in the process of liquidation of its remaining assets.

AI Brief Pro

The brief on Evolva Holding SA

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Evolva Holding SA?

EvoNext Holdings SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors. The company is listed on the LSE in UK, with a market capitalisation of 740.34M.

Financial Highlights

Investment Breakdown

Growth
Revenue growth is subdued, limiting near-term earnings expansion.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Low (31)
Company Information
SectorN/A
IndustryN/A
Market Cap740.34M
Beta-0.042
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.